BEIT JALA PHARMACEUTICAL COMPANY |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.8 JOD | +1.45% |
|
-.--% | -.--% |
| Sales 2022 | 10.77M 15.21M | Sales 2023 | 9.61M 13.58M | Capitalization | 19.6M 27.69M |
|---|---|---|---|---|---|
| Net income 2022 | 1M 1.41M | Net income 2023 | 1M 1.41M | EV / Sales 2022 | 1.92 x |
| Net Debt 2022 | 744K 1.05M | Net Debt 2023 | 236K 334K | EV / Sales 2023 | 2.06 x |
| P/E ratio 2022 |
10.1
x | P/E ratio 2023 |
10.7
x | Employees | 222 |
| Yield 2022 |
3.51% | Yield 2023 |
-
| Free-Float | 20.36% |
More Fundamentals
* Assessed data
More news
| 1 day | +1.45% |
1 year
2.70
2.80
3 years
2.562.90
5 years
2.412.90
10 years
1.532.90
| Managers | Title | Age | Since |
|---|---|---|---|
Waleed Mousa
CEO | Chief Executive Officer | - | 90-12-31 |
Fakhri Ghiwa
DFI | Director of Finance/CFO | - | 03-12-31 |
Rashid Maraqa
CTO | Chief Tech/Sci/R&D Officer | - | 95-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Nidal Sukhtian
CHM | Chairman | - | - |
| Corporate Officer/Principal | 60 | - | |
| Director/Board Member | - | 89-12-31 |
Beit Jala Pharmaceutical Manufacturing Co is a Palestine occupied territories-based pharmaceutical company. The Company develops several pharmaceutical products such as tablets, capsules, ointments, and creams. Its product portfolio includes solid, liquids, semi solids and sterile products. Beit Jala Poland is subsidiary of the Company.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 27.65M | |
| +24.97% | 556B | |
| -6.33% | 354B | |
| +19.90% | 331B | |
| +7.95% | 296B | |
| +14.30% | 233B | |
| +6.04% | 201B | |
| -10.10% | 193B | |
| -12.26% | 143B | |
| -6.47% | 144B |
- Stock Market
- Equities
- BJP Stock
